Abstract
The PHLDA family (pleckstrin homology-like domain family) of genes consists of 3 members: PHLDA1, 2, and 3. Both PHLDA3 and PHLDA2 are phosphatidylinositol (PIP) binding proteins and function as repressors of Akt. They have tumor suppressive functions, mainly through Akt inhibition. Several reports suggest that PHLDA1 also has a tumor suppressive function; however, the precise molecular functions of PHLDA1 remain to be elucidated. Through a comprehensive screen for p53 target genes, we identified PHLDA1 as a novel p53 target, and we show that PHLDA1 has the ability to repress Akt in a manner similar to that of PHLDA3 and PHLDA2. PHLDA1 has a so-called split PH domain in which the PH domain is divided into an N-terminal (β sheets 1-3) and a C-terminal (β sheets 4-7 and an α-helix) portions. We show that the PH domain of PHLDA1 is responsible for its localization to the plasma membrane and binding to phosphatidylinositol. We also show that the function of the PH domain is essential for Akt repression. In addition, PHLDA1 expression analysis suggests that PHLDA1 has a tumor suppressive function in breast and ovarian cancers.
Keywords:
Akt; PH domain; PHLDA family; p53; tumor suppressor.
© 2018 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
MeSH terms
-
Alternative Splicing
-
Animals
-
Breast Neoplasms / genetics*
-
Cell Line, Tumor
-
Cell Membrane / metabolism
-
Female
-
Gene Expression Regulation, Neoplastic
-
HCT116 Cells
-
HEK293 Cells
-
HeLa Cells
-
Humans
-
Neoplasm Transplantation
-
Ovarian Neoplasms / genetics*
-
Phosphatidylinositols / metabolism
-
Protein Binding
-
Proto-Oncogene Proteins c-akt / metabolism*
-
Transcription Factors / chemistry
-
Transcription Factors / genetics*
-
Transcription Factors / metabolism*
-
Tumor Suppressor Protein p53 / metabolism*
Substances
-
PHLDA1 protein, human
-
Phosphatidylinositols
-
TP53 protein, human
-
Transcription Factors
-
Tumor Suppressor Protein p53
-
Proto-Oncogene Proteins c-akt
Grants and funding
-
#17H03587/The Ministry of Education, Culture, Sports, Science and Technology of Japan
-
#17H07378/The Ministry of Education, Culture, Sports, Science and Technology of Japan
-
#15K19537/The Ministry of Education, Culture, Sports, Science and Technology of Japan
-
Research for Innovative Treatment of Cancer from the Ministry of Health, Labour and Welfare
-
Development of Innovative Research on Cancer Therapeutics P-DIRECT/Ministry of Education, Culture, Sports, Science and Technology of Japan
-
Princess Takamatsu Cancer Research
-
Mitsubishi Foundation
-
NOVARTIS Foundation (Japan) for the Promotion of Science
-
Project Mirai Cancer Research
-
Okinaka Memorial Institute for Medical Research
-
National Cancer Center Research and Development Fund
-
Life Science Foundation of Japan
-
Foundation for Promotion of Cancer Research in Japan
-
Applied Research for Innovative Treatment of Cancer from the Ministry of Health, Labour and Welfare